With multiple drug candidates in the clinic that originated from fragment-based lead discovery, the approach of starting small has become big.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
NMR quality control of fragment libraries for screening
Journal of Biomolecular NMR Open Access 12 June 2020
-
Identification of DNA primase inhibitors via a combined fragment-based and virtual screening
Scientific Reports Open Access 02 November 2016
-
Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities
Nature Communications Open Access 22 September 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Baker, M. Fragment-based lead discovery grows up. Nat Rev Drug Discov 12, 5–7 (2013). https://doi.org/10.1038/nrd3926
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3926
This article is cited by
-
Towards systematic exploration of chemical space: building the fragment library module in molecular property diagnostic suite
Molecular Diversity (2023)
-
Synthon-based ligand discovery in virtual libraries of over 11 billion compounds
Nature (2022)
-
Fragment-based inhibitor design for SARS-CoV2 main protease
Structural Chemistry (2022)
-
Plant natural fragments, an innovative approach for drug discovery
Phytochemistry Reviews (2020)
-
NMR quality control of fragment libraries for screening
Journal of Biomolecular NMR (2020)